← Leaderboards
Linda Theresa Vahdat
Weill Medical Coll Of Cornell Univ
$1,571,187
Attributed
$3,142,373
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $989K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,142,373 · 2
By mechanism
R01$3,142,373 · 2
Top collaborators
- Vivek Mittal6 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Fernando J Martinez$34,787,404
- Vivek Mittal$10,850,597
- Steven Monroe Lipkin$27,661,021
- Augustine M Choi$36,719,348
- Maria Plataki$1,527,839
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingOralExhibitsLoxl2 GeneMetabolic PathwayNeoplastic CellChelating AgentsDistalHigh RiskImpairmentCollagenCopperMitochondriaNeoplasm MetastasisBioenergeticsBiological MarkersCellsCrosslinkClinical TrialsGlycolysisBreast Cancer PatientCancer CellAffectOrgan
Grant awards (6)
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$546,681
R01 · FY2025 · CA
Therapeutic targeting of the tumor microenvironment in triple negative breast cancer patients at high risk of relapse and preclinical models of lung metastases$442,343
R01 · FY2025 · CA · contact PI
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$519,193
R01 · FY2024 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$535,436
R01 · FY2023 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$535,285
R01 · FY2022 · CA
Copper-mediated metabolic reprogramming and ECM alterations in TNBC metastasis$563,435
R01 · FY2021 · CA